Pacific Biosciences of California laid off 130 employees, more than a quarter of its workforce, the company said Tuesday.
The Menlo Park developer of gene sequencing equipment (NASDAQ: PACB) said the moves will conserve cash as it tries to grow its customer base.
PacBio said it expects to end the third quarter with about $190 million.
No comments:
Post a Comment